Propanolamines
"Propanolamines" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
AMINO ALCOHOLS containing the propanolamine (NH2CH2CHOHCH2) group and its derivatives.
Descriptor ID |
D011412
|
MeSH Number(s) |
D02.033.100.624 D02.033.755.624 D02.092.063.624
|
Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Propanolamines".
Below are MeSH descriptors whose meaning is more specific than "Propanolamines".
This graph shows the total number of publications written about "Propanolamines" by people in this website by year, and whether "Propanolamines" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
Year | Major Topic | Minor Topic | Total |
---|
1986 | 1 | 0 | 1 | 1990 | 2 | 0 | 2 | 1996 | 1 | 0 | 1 | 2003 | 1 | 0 | 1 | 2008 | 0 | 1 | 1 | 2011 | 1 | 0 | 1 | 2015 | 1 | 0 | 1 | 2016 | 0 | 1 | 1 | 2018 | 1 | 0 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Propanolamines" by people in Profiles.
-
De Oliveira GS, Kendall MC, McCarthy RJ. Esmolol does not improve quality of postsurgical recovery after ambulatory hysteroscopy: A prospective, randomized, double-blinded, placebo-controlled, clinical trial. Medicine (Baltimore). 2018 Oct; 97(41):e12647.
-
Tan Z, Xiao Z, Wei J, Zhang J, Zhou Q, Smith CD, Nani A, Wu G, Song LS, Back TG, Fill M, Chen SR. Nebivolol suppresses cardiac ryanodine receptor-mediated spontaneous Ca2+ release and catecholaminergic polymorphic ventricular tachycardia. Biochem J. 2016 Nov 15; 473(22):4159-4172.
-
Zhang J, Zhou Q, Smith CD, Chen H, Tan Z, Chen B, Nani A, Wu G, Song LS, Fill M, Back TG, Chen SR. Non-ß-blocking R-carvedilol enantiomer suppresses Ca2+ waves and stress-induced ventricular tachyarrhythmia without lowering heart rate or blood pressure. Biochem J. 2015 Sep 01; 470(2):233-42.
-
Zhou Q, Xiao J, Jiang D, Wang R, Vembaiyan K, Wang A, Smith CD, Xie C, Chen W, Zhang J, Tian X, Jones PP, Zhong X, Guo A, Chen H, Zhang L, Zhu W, Yang D, Li X, Chen J, Gillis AM, Duff HJ, Cheng H, Feldman AM, Song LS, Fill M, Back TG, Chen SR. Carvedilol and its new analogs suppress arrhythmogenic store overload-induced Ca2+ release. Nat Med. 2011 Jul 10; 17(8):1003-9.
-
Desantiago J, Ai X, Islam M, Acuna G, Ziolo MT, Bers DM, Pogwizd SM. Arrhythmogenic effects of beta2-adrenergic stimulation in the failing heart are attributable to enhanced sarcoplasmic reticulum Ca load. Circ Res. 2008 Jun 06; 102(11):1389-97.
-
Liebson PR. AVID and COMET. Prev Cardiol. 2003; 6(4):218-20.
-
O'Connor CJ, Rothenberg DM, Soble JS, Macioch JE, McCarthy R, Neumann A, Tuman KJ. The effect of esmolol pretreatment on the incidence of regional wall motion abnormalities during electroconvulsive therapy. Anesth Analg. 1996 Jan; 82(1):143-7.
-
Tuman KJ, McCarthy RJ, Wong CA, Labarge AM, Spiess BD, Ivankovich AD. Comparative effects of esmolol and verapamil in a model of a supraventricular tachydysrhythmia. Anesthesiology. 1990 Sep; 73(3):467-73.
-
Parnass SM, Rothenberg DM, Kerchberger JP, Ivankovich AD. A single bolus dose of esmolol in the prevention of intubation-induced tachycardia and hypertension in an ambulatory surgery unit. J Clin Anesth. 1990 Jul-Aug; 2(4):232-7.
-
Steinberg JS, Katz RJ, Somberg JC, Keefe D, Laddu AR, Burge J. Safety and efficacy of flestolol, a new ultrashort-acting beta-adrenergic blocking agent, for supraventricular tachyarrhythmias. Am J Cardiol. 1986 Nov 01; 58(10):1005-8.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|